Company intelligence / Profile preview

Lobe Sciences Ltd.

Vancouver*, British Columbia*, Canada*lobesciences.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Lobe Sciences has achieved first-in-human clinical data with its oral psilocin candidate L‑130, demonstrating improved pharmacokinetics and shelf stability. Its medical food product Altemia® generated CAD $1.1M in sales in 2023 and is commercially available for Sickle Cell Disease. The company’s lead pharmaceutical program, Conjugated Psilocin™, targets chronic cluster headache and has secured new patent protection; it is advancing through early clinical stages with recent funding to support Phase 1/2a studies[3][5][7].

Therapeutic areas: HematologyNeurology
Modalities: Small molecules (notably stabilized/conjugated psilocin compounds)Medical foods[6][3]
Industry: Biotech

Drug pipeline

2 assets

Altemia

1 more asset in the full pipeline.

Request access →

Partnerships

Pentec Health — exclusive collaboration for launch/distribution of Altemia® [3].Clearway Global — assists with manufacturing/regulatory/clinical programs [4].

Beyond the preview

Go deeper on Lobe Sciences Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lobe Sciences Ltd..

Explore the full profile